Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
62.79
-0.40 (-0.63%)
Mar 31, 2025, 9:53 AM EDT - Market open
Haemonetics Employees
Haemonetics had 3,657 employees as of March 30, 2024. The number of employees increased by 623 or 20.53% compared to the previous year.
Employees
3,657
Change (1Y)
623
Growth (1Y)
20.53%
Revenue / Employee
$375,585
Profits / Employee
$35,566
Market Cap
3.15B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HAE News
- 27 days ago - Haemonetics Announces Executive Leadership Updates - PRNewsWire
- 5 weeks ago - Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - PRNewsWire
- 7 weeks ago - Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Haemonetics 3rd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website - PRNewsWire
- 2 months ago - Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A - PRNewsWire
- 2 months ago - Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025 - PRNewsWire
- 3 months ago - Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 months ago - Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A - PRNewsWire